
The global Diagnostics PCR market size is predicted to grow from US$ 559 million in 2025 to US$ 640 million in 2031; it is expected to grow at a CAGR of 2.3% from 2025 to 2031.
PCR is the Gold Standard in Diagnostic Testing. Polymerase chain reaction (PCR) is able to copy and multiply specific target DNA molecules has opened the door to diagnosing diseases across multiple areas quickly, accurately, and as time progresses at lower cost. Polymerase chain reaction (PCR) is a quick, easy way to create unlimited copies of DNA from just one original strand. These millions of copies of a section of DNA are made in just a few hours with the goal to recreate enough DNA for multiple testing uses, such as sequencing or infection identification.
Global Diagnostics PCR key players include Thermo Fisher Scientific, Bio-rad, Roche, Qiagen, Bioer, etc. Global top five manufacturers hold a share over 75%. North America is the largest market, with a share over 40%, followed by Europe and China, total have a share over 40 percent. In terms of product, Real-Time PCR is the largest segment, with a share about 55%. And in terms of application, the largest application is Hospital, followed by Independent Laboratories.
The “Diagnostics PCR Industry Forecast” looks at past sales and reviews total world Diagnostics PCR sales in 2024, providing a comprehensive analysis by region and market sector of projected Diagnostics PCR sales for 2025 through 2031. With Diagnostics PCR sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diagnostics PCR industry.
This Insight Report provides a comprehensive analysis of the global Diagnostics PCR landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diagnostics PCR portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diagnostics PCR market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diagnostics PCR and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diagnostics PCR.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostics PCR market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Real-Time PCR
Digital PCR
Other
Segmentation by Application:
Hospital
Independent Laboratories
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Roche
Bio-rad
Qiagen
Agilent
Bioer
Analytik Jena
Techne
Biosynex
Key Questions Addressed in this Report
What is the 10-year outlook for the global Diagnostics PCR market?
What factors are driving Diagnostics PCR market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Diagnostics PCR market opportunities vary by end market size?
How does Diagnostics PCR break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diagnostics PCR Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Diagnostics PCR by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Diagnostics PCR by Country/Region, 2020, 2024 & 2031
2.2 Diagnostics PCR Segment by Type
2.2.1 Real-Time PCR
2.2.2 Digital PCR
2.2.3 Other
2.3 Diagnostics PCR Sales by Type
2.3.1 Global Diagnostics PCR Sales Market Share by Type (2020-2025)
2.3.2 Global Diagnostics PCR Revenue and Market Share by Type (2020-2025)
2.3.3 Global Diagnostics PCR Sale Price by Type (2020-2025)
2.4 Diagnostics PCR Segment by Application
2.4.1 Hospital
2.4.2 Independent Laboratories
2.4.3 Other
2.5 Diagnostics PCR Sales by Application
2.5.1 Global Diagnostics PCR Sale Market Share by Application (2020-2025)
2.5.2 Global Diagnostics PCR Revenue and Market Share by Application (2020-2025)
2.5.3 Global Diagnostics PCR Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Diagnostics PCR Breakdown Data by Company
3.1.1 Global Diagnostics PCR Annual Sales by Company (2020-2025)
3.1.2 Global Diagnostics PCR Sales Market Share by Company (2020-2025)
3.2 Global Diagnostics PCR Annual Revenue by Company (2020-2025)
3.2.1 Global Diagnostics PCR Revenue by Company (2020-2025)
3.2.2 Global Diagnostics PCR Revenue Market Share by Company (2020-2025)
3.3 Global Diagnostics PCR Sale Price by Company
3.4 Key Manufacturers Diagnostics PCR Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Diagnostics PCR Product Location Distribution
3.4.2 Players Diagnostics PCR Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Diagnostics PCR by Geographic Region
4.1 World Historic Diagnostics PCR Market Size by Geographic Region (2020-2025)
4.1.1 Global Diagnostics PCR Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Diagnostics PCR Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Diagnostics PCR Market Size by Country/Region (2020-2025)
4.2.1 Global Diagnostics PCR Annual Sales by Country/Region (2020-2025)
4.2.2 Global Diagnostics PCR Annual Revenue by Country/Region (2020-2025)
4.3 Americas Diagnostics PCR Sales Growth
4.4 APAC Diagnostics PCR Sales Growth
4.5 Europe Diagnostics PCR Sales Growth
4.6 Middle East & Africa Diagnostics PCR Sales Growth
5 Americas
5.1 Americas Diagnostics PCR Sales by Country
5.1.1 Americas Diagnostics PCR Sales by Country (2020-2025)
5.1.2 Americas Diagnostics PCR Revenue by Country (2020-2025)
5.2 Americas Diagnostics PCR Sales by Type (2020-2025)
5.3 Americas Diagnostics PCR Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diagnostics PCR Sales by Region
6.1.1 APAC Diagnostics PCR Sales by Region (2020-2025)
6.1.2 APAC Diagnostics PCR Revenue by Region (2020-2025)
6.2 APAC Diagnostics PCR Sales by Type (2020-2025)
6.3 APAC Diagnostics PCR Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Diagnostics PCR by Country
7.1.1 Europe Diagnostics PCR Sales by Country (2020-2025)
7.1.2 Europe Diagnostics PCR Revenue by Country (2020-2025)
7.2 Europe Diagnostics PCR Sales by Type (2020-2025)
7.3 Europe Diagnostics PCR Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Diagnostics PCR by Country
8.1.1 Middle East & Africa Diagnostics PCR Sales by Country (2020-2025)
8.1.2 Middle East & Africa Diagnostics PCR Revenue by Country (2020-2025)
8.2 Middle East & Africa Diagnostics PCR Sales by Type (2020-2025)
8.3 Middle East & Africa Diagnostics PCR Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Diagnostics PCR
10.3 Manufacturing Process Analysis of Diagnostics PCR
10.4 Industry Chain Structure of Diagnostics PCR
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Diagnostics PCR Distributors
11.3 Diagnostics PCR Customer
12 World Forecast Review for Diagnostics PCR by Geographic Region
12.1 Global Diagnostics PCR Market Size Forecast by Region
12.1.1 Global Diagnostics PCR Forecast by Region (2026-2031)
12.1.2 Global Diagnostics PCR Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Diagnostics PCR Forecast by Type (2026-2031)
12.7 Global Diagnostics PCR Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Information
13.1.2 Thermo Fisher Scientific Diagnostics PCR Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Diagnostics PCR Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Thermo Fisher Scientific Main Business Overview
13.1.5 Thermo Fisher Scientific Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Diagnostics PCR Product Portfolios and Specifications
13.2.3 Roche Diagnostics PCR Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Bio-rad
13.3.1 Bio-rad Company Information
13.3.2 Bio-rad Diagnostics PCR Product Portfolios and Specifications
13.3.3 Bio-rad Diagnostics PCR Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bio-rad Main Business Overview
13.3.5 Bio-rad Latest Developments
13.4 Qiagen
13.4.1 Qiagen Company Information
13.4.2 Qiagen Diagnostics PCR Product Portfolios and Specifications
13.4.3 Qiagen Diagnostics PCR Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Qiagen Main Business Overview
13.4.5 Qiagen Latest Developments
13.5 Agilent
13.5.1 Agilent Company Information
13.5.2 Agilent Diagnostics PCR Product Portfolios and Specifications
13.5.3 Agilent Diagnostics PCR Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Agilent Main Business Overview
13.5.5 Agilent Latest Developments
13.6 Bioer
13.6.1 Bioer Company Information
13.6.2 Bioer Diagnostics PCR Product Portfolios and Specifications
13.6.3 Bioer Diagnostics PCR Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bioer Main Business Overview
13.6.5 Bioer Latest Developments
13.7 Analytik Jena
13.7.1 Analytik Jena Company Information
13.7.2 Analytik Jena Diagnostics PCR Product Portfolios and Specifications
13.7.3 Analytik Jena Diagnostics PCR Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Analytik Jena Main Business Overview
13.7.5 Analytik Jena Latest Developments
13.8 Techne
13.8.1 Techne Company Information
13.8.2 Techne Diagnostics PCR Product Portfolios and Specifications
13.8.3 Techne Diagnostics PCR Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Techne Main Business Overview
13.8.5 Techne Latest Developments
13.9 Biosynex
13.9.1 Biosynex Company Information
13.9.2 Biosynex Diagnostics PCR Product Portfolios and Specifications
13.9.3 Biosynex Diagnostics PCR Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Biosynex Main Business Overview
13.9.5 Biosynex Latest Developments
14 Research Findings and Conclusion
*If Applicable.
